|
Symbol
|
P322TQ | PMWLTQ | WEVLTQ | LTARCH | WXNLTQ | EOJRCH | XRYLTQ | RMABXV | YOTLTQ | RMBWDV | RMAVSV | Z0972Z | Z0974Z | Z0973Z | BTJBKB | ZPRLTQ | OCGRCH | HZJEFG | BZFBKB | ABOOSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Geberit AG / Givaudan / Holcim/Amrize Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche AG / Swatch Group I / Swiss RE AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Lonza Group N / Roche GS / Sika AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 09.02.2026 | 31.03.2028 | 24.09.2027 | 30.06.2028 | 14.01.2026 | 22.09.2028 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 02.11.2026 | 12.07.2027 | 05.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
66,90 | 56,45 | 71,27 | 401,50 | 58,95 | 287,84 | 160,62 | 182,96 | 178,20 | 63,33 | 47,42 | 22,9033 | 22,9279 | 22,9033 | 68,75 | 63,975 | 58,5776 | 182,298 | 183,056 | 177,072 |
| rendement max. p.a. | 133,86% | - | 5,10% | - | 6,34% | -5,18% | 9,50% | 9,72% | 6,02% | 4,59% | 79,19% | 3,93% | 7,71% | 6,02% | 3,65% | 3,06% | 4,19% | - | 12,80% | 12,09% |
| Demande | - | 95,99 | 100,69 | - | 94,91 | 100,78 | 87,12 | 95,90 | 96,22 | 100,00 | 79,00 | - | - | - | 100,41 | 103,42 | - | 86,68 | 91,72 | 88,00 |
| Offre | - | - | 101,50 | - | 95,71 | 101,59 | 87,92 | 96,70 | 97,02 | 101,00 | 86,00 | - | - | - | 101,22 | 104,25 | - | - | 92,52 | - |